Gastric Carcinoma clinical trials

Explore recruiting gastric carcinoma clinical trials.

Recruiting gastric carcinoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Gastric Carcinoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Preoperative intraperitoneal chemotherapy in adjuvant hyperthermia adjunctive therapy in advanced gastric cancer with high-risk of peritoneal recurrence - a multicentre randomized trial.

Poland

Phase II and Phase III (Integrated) EU CTIS Study details

GASTRICHIP TRIAL. D2 resection and HIPEC (Hyperthermic IntraPeritoneal Chemoperfusion) in locally advanced gastric carcinoma. A randomized and multicentric phase III study

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 2/3 Study of ALX148 in Patients with Advanced HER2-Overexpressing Gastric/Gastroesophageal Junction Adenocarcinoma (ASPEN-06)

Belgium, Spain, Italy, Czechia, France

Phase II and Phase III (Integrated) EU CTIS Study details

A Randomized, Multicenter, Phase 3 Study of Zanidatamab in Combination with Chemotherapy with or without Tislelizumab in Subjects with HER2-positive Unresectable Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma (GEA)

Romania, Ireland, Germany, Greece, Netherlands, Estonia +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

REGOMUNE : A phase I/II study of Regorafenib plus Avelumab in solid tumors

France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

PET-imaging of two Vartumabs (F8scFv and C9scFv) in patients with solid tumors – a Phase 0 basket trial

Netherlands

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Gastric Carcinoma trials by city

Gastric Carcinoma in Toronto Gastric Carcinoma in Vancouver Gastric Carcinoma in Montreal Gastric Carcinoma in Calgary Gastric Carcinoma in Edmonton Gastric Carcinoma in Ottawa Gastric Carcinoma in Winnipeg Gastric Carcinoma in Quebec City Gastric Carcinoma in Hamilton Gastric Carcinoma in Kitchener Gastric Carcinoma in London Gastric Carcinoma in Halifax Gastric Carcinoma in New York Gastric Carcinoma in Los Angeles Gastric Carcinoma in Chicago Gastric Carcinoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease